Back to results
US 6,552,038 B1Granted
Anticoagulant agents
AssigneeEli Lilly and Company
InventorsValentine Joseph Klimkowski, Aaron Leigh Schacht, Michael Robert Wiley
Life of this patent
Estimating the term…
Abstract
This invention relates to a compound of the Formula I X—C(O)—Y—G—R I (wherein X, Y, G and R have the values defined in the description), or a pharmaceutically acceptable salt thereof, processes and intermediates for the preparation of such a compound or salt, pharmaceutical compositions comprising such a compound or salt and methods of their use as thrombin inhibitors, coagulation inhibitors and agents for the treatment of thromboembolic disorders.
Claims13
A compound having the Formula I
- X—C(O)—Y—G—R I
- wherein
- X—C(O)— is D-homoprolinyl,
- Rm—(CH2)g—NH—CH2—C(O)—,
- in which
- Rd is carboxy or methylsulfonyl;
- Re is NHRC, NHCORC or NHCOORC;
- in which
- RC is (C1—C10)alkyl, (C3-C8)cycloalkyl or a (C3—C8)cycloalkyl—(C1—C6)alkyl radical of 4-10 carbons;
- T is (C3—C8)cycloalkyl, (C1—C8)alkyl,
- a is 0, 1 or 2;
- and
- Q is —OH, (C1—C4)alkoxy, or —NH—A;
- A is hydrogen, (C1—C4)alkyl, R″SO2—, R″OC(O)—, R″C(O)—, RnC(O)— or —(CH2)g-Rm;
- g is 1, 2, or 3;
- B is hydrogen or (C1—C4)alkyl;
- R′ is hydrogen or (C1—C4)alkyl;
- R″ is (C1—C4)alkyl, (C1—C4)fluoroalkyl bearing one to five fluoros, —(CH2)d-Rm, or unsubstituted or substituted aryl, where aryl is phenyl, naphthyl, a 5- or 6-membered unsubstituted or substituted aromatic heterocyclic ring, having one or two heteroatoms which are the same or different and which are selected from sulfur, oxygen and nitrogen, or a 9- or 10-membered unsubstituted or substituted fused bicyclic aromatic heterocyclic group having one or two heteroatoms which are the same or different and which are selected from sulfur, oxygen and nitrogen;
- provided that when A is R″SO2—, R″ is not (C1-C4)alkyl, (C1-C4)fluoroalkyl bearing one to five fluoros, —(CH2)d-Rm, or unsubstituted or substituted aryl, where aryl is phenyl or naphthyl;
- Rm is —COORb, —SO2(C1-C4 alkyl), —SO3H, —P(O)(ORb)2 or tetrazol-5-yl;
- Rn is —COORb or tetrazol-5-yl;
- each Rb is independently hydrogen or (C1-C4)alkyl;
- d is 1, 2, or 3;
- m is 0 or 2;
- n is 0, 1, or 2;
- and
- Z is hydrogen, (C1-C4)alkyl, (C1-C4)alkoxy, hydroxy, halo or (C1—C4)alkylsulfonylamino;
- —Y—G— is
- —NRg—CH2—G—,
- or
- in which
- r is 0, 1 or 2;
- Rg is (C1-C6)alkyl, (C3-C8)cycloalkyl, or —(CH2)p-L-(CH2)q-T′;
- RP is (C1-C6)alkyl, (C3-C8)cycloalkyl, or —(CH2)p-L-(CH2)q-T′;
- where p is 0, 1 , 2, 3, or 4;
- L is a bond, —O—, —S—, or —NH—;
- q is 0, 1, 2 or 3;
- and T′ is (C1-C4)alkyl, (C3—C8)cycloalkyl, —COOH, —CONH2, or Ar, where Ar is unsubstituted or substituted aryl, where aryl is phenyl, naphthyl, a 5- or 6-membered unsubstituted or substituted aromatic heterocyclic ring, having one or two heteroatoms which are the same or different and which are selected from sulfur, oxygen and nitrogen, or a 9- or 10-membered unsubstituted or substituted fused bicyclic aromatic heterocyclic group having one or two heteroatoms which are the same or different and which are selected from sulfur, oxygen and nitrogen;
- Ry is —CH2—, —O—, —S—, or —NH—;
- and
- RZ is a bond or, when taken with Ry and the three adjoining carbon atoms, forms a saturated carbocyclic ring of 5-8 atoms, one atom of which may be —O—, —S—, or —NH—;
- —G—R is —C(O)—NH—(CH2)s—R, CH2—NH—(CH2)s—R, —CH2—NH—C(O)—R or —(CH2)t—O—R in which s is 1 or 2 and t is 1 , 2 or 3;
- and
- R is a 4-amidino-3-hydroxyphenyl group bearing 0, 1, 2 or 3 fluoro substituents;
- or a pharmaceutically acceptable salt thereof.
42 more elements
Dependencies are inferred from the claim text.